Biogen Inc.
BIIB · NASDAQ
Financial statements
Annual and quarterly income, balance-sheet, cash-flow and key-statistics data.
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2022 FY | 10.17B | 7.90B | 2.89B | 3.05B | 20.97 |
| 2023 FY | 9.84B | 7.30B | 2.10B | 1.16B | 8.02 |
| 2024 FY | 9.68B | 7.37B | 2.49B | 1.63B | 11.20 |
| 2025 FY | 9.81B | 6.91B | 1.88B | 1.29B | 8.85 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2022 FY | 24.55B | 11.17B | 3.42B | 6.61B | 13.40B |
| 2023 FY | 26.84B | 12.05B | 1.05B | 7.34B | 14.80B |
| 2024 FY | 28.05B | 11.33B | 2.38B | 6.63B | 16.72B |
| 2025 FY | 29.44B | 11.18B | 3.01B | 6.95B | 18.26B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2022 FY | 1.38B | -240.30M | 1.14B | — | 1.16B |
| 2023 FY | 1.55B | -311.40M | 1.24B | — | -2.37B |
| 2024 FY | 2.88B | -359.80M | 2.52B | — | 1.33B |
| 2025 FY | 2.20B | -153.80M | 2.05B | — | 633.50M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2022 FY | 40.24B | 43.43B | — | — | — |
| 2023 FY | 37.44B | 43.73B | — | — | — |
| 2024 FY | 22.28B | 26.54B | — | — | — |
| 2025 FY | 25.82B | 29.76B | — | — | — |
| 2026-12-31 | — | — | — | — | — |
| 2027-12-31 | — | — | — | — | — |
| 2028-12-31 | — | — | — | — | — |
Income statement
| Period | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 Q2 | 2.65B | 1.70B | 588.10M | 634.80M | 4.35 |
| 2025 Q3 | 2.45B | 1.58B | 613.80M | 466.50M | 3.18 |
| 2025 Q4 | 2.28B | 1.78B | -57.00M | -48.41M | -0.33 |
| 2026 Q1 | 2.48B | 1.82B | 397.40M | 319.50M | 2.17 |
Balance sheet
| Period | Total assets | Liabilities | Cash | Debt | Equity |
|---|---|---|---|---|---|
| 2025 Q2 | 28.33B | 10.70B | 2.76B | 6.59B | 17.63B |
| 2025 Q3 | 29.21B | 11.00B | 3.86B | 6.59B | 18.21B |
| 2025 Q4 | 29.44B | 11.18B | 3.01B | 6.95B | 18.26B |
| 2026 Q1 | 29.48B | 10.83B | 3.38B | 6.56B | 18.65B |
Cash flow
| Period | Operating cash flow | Capital expenditure | Free cash flow | Dividends paid | Net cash change |
|---|---|---|---|---|---|
| 2025 Q2 | 160.90M | -16.60M | 144.30M | — | 160.50M |
| 2025 Q3 | 1.27B | -46.20M | 1.23B | — | 1.10B |
| 2025 Q4 | 512.00M | 43.90M | 555.90M | — | -856.60M |
| 2026 Q1 | 645.50M | 51.20M | 696.70M | — | 374.20M |
Key statistics
| Period | Market cap | Enterprise value | P/E | Price / sales | Debt / equity |
|---|---|---|---|---|---|
| 2025 Q2 | 18.32B | 22.16B | — | — | — |
| 2025 Q3 | 20.54B | 23.26B | — | — | — |
| 2025 Q4 | 25.82B | 29.76B | — | — | — |
| 2026 Q1 | 26.99B | 30.17B | — | — | — |
| 2026-06-30 | — | — | — | — | — |
| 2026-09-30 | — | — | — | — | — |
| 2026-12-31 | — | — | — | — | — |